Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Glucose 40% infusion 500ml
0902021G0AABEBE
|
Glucose (Parenteral) | Glucose | Nutrition and Blood | No data available |
|
Glucose 5% / Lidocaine 1g/500ml (0.2%) infusion 500ml
0203020L0AAAEAE
|
Lidocaine hydrochloride (Ventricular Arrhythmias) | Lidocaine hydrochloride | Cardiovascular System | No data available |
|
Glucose 5% / Lidocaine 2g/500ml (0.4%) infusion 500ml bags
0203020L0AAAGAG
|
Lidocaine hydrochloride (Ventricular Arrhythmias) | Lidocaine hydrochloride | Cardiovascular System | No data available |
|
Glucose 5% in half strength Hartmann's infusion 500ml bags
0902021V0AAAFAF
|
Sodium lactate (Parenteral) | Sodium lactate | Nutrition and Blood | No data available |
|
Glucose 5% infusion 100ml Freeflex bags
0902021G0BGAAA3
|
Freeflex glucose | Glucose | Nutrition and Blood | No data available |
|
Glucose 5% infusion 100ml Freeflex Plus bags
0902021G0BGAEA3
|
Freeflex glucose | Glucose | Nutrition and Blood | No data available |
|
Glucose 5% infusion 100ml Viaflex bags
0902021G0BBAEA3
|
Baxter glucose | Glucose | Nutrition and Blood | No data available |
|
Glucose 5% infusion 150ml Viaflex bags
0902021G0BBAHA0
|
Baxter glucose | Glucose | Nutrition and Blood | No data available |
|
Glucose 5% infusion 1litre Freeflex bags
0902021G0BGADBD
|
Freeflex glucose | Glucose | Nutrition and Blood | No data available |
|
Glucose 5% infusion 1litre Viaflex bags
0902021G0BBAABD
|
Baxter glucose | Glucose | Nutrition and Blood | No data available |
|
Glucose 5% infusion 250ml bags
0902021G0AAAUAU
|
Glucose (Parenteral) | Glucose | Nutrition and Blood | No data available |
|
Glucose 5% infusion 250ml Freeflex bags
0902021G0BGABAU
|
Freeflex glucose | Glucose | Nutrition and Blood | No data available |
|
Glucose 5% infusion 250ml Freeflex Plus bags
0902021G0BGAFAU
|
Freeflex glucose | Glucose | Nutrition and Blood | No data available |
|
Glucose 5% infusion 250ml Viaflex bags
0902021G0BBAIAU
|
Baxter glucose | Glucose | Nutrition and Blood | No data available |
|
Glucose 5% infusion 500ml Freeflex bags
0902021G0BGACBC
|
Freeflex glucose | Glucose | Nutrition and Blood | No data available |
|
Glucose 5% infusion 500ml Freeflex Plus bags
0902021G0BGAGBC
|
Freeflex glucose | Glucose | Nutrition and Blood | No data available |
|
Glucose 5% infusion 500ml Viaflex bags
0902021G0BBABBC
|
Baxter glucose | Glucose | Nutrition and Blood | No data available |
|
Glucose 50% in glycerol nasal drops
1202020F0AAAHAH
|
Glucose/glycerol | Glucose/glycerol | Ear, Nose and Oropharynx | No data available |
|
Glucose 50% inf 50ml Minijet pre-filled syringes
0902021G0BCAABH
|
Minjet glucose | Glucose | Nutrition and Blood | No data available |
|
Glucose 50% infusion 500ml
0902021G0AAAYAY
|
Glucose (Parenteral) | Glucose | Nutrition and Blood | No data available |
|
Glucose 50% solution for infusion 20ml ampoules
0902021G0AAADAD
|
Glucose (Parenteral) | Glucose | Nutrition and Blood | No data available |
|
Glucose 50% solution for infusion 50ml ampoules
0902021G0AAAFAF
|
Glucose (Parenteral) | Glucose | Nutrition and Blood | No data available |
|
Glucose 50% solution for infusion 50ml pre-filled syringes
0902021G0AABHBH
|
Glucose (Parenteral) | Glucose | Nutrition and Blood | No data available |
|
Glucose 75g/300ml oral solution
0601040I0AAAEAE
|
Glucose (Hypoglycaemia) | Glucose | Endocrine System | No data available |
|
Glucose liquid
0913541B0AAACAC
|
Liquid OTC glucose for diabetic hypo treatment (0913541) | Liquid OTC glucose for diabetic hypo treatment (0913541) | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.